Table I.
SjS (n = 57) | NV (n = 25) | |
---|---|---|
Age, years (mean, ± SD) | 53 (± 13) | 48 (± 14) |
Percent Female | 83% | 60% |
Unstimulated Salivary Flow, mL/15 min (mean, ± SD) | 1.30 (± 2.30) | 3.39 (± 3.39) |
Focus Score* (mean, ± SD) | 4 (± 4) | 0 (± 1) |
Schirmer’s test, mm/5 min (mean, ± SD) | 5 (± 7) | 14 (± 11) |
Anti-SSA positive by ELISA† (%) | 72 | 0 |
Anti-SSB positive by ELISA† (%) | 46 | 0 |
RF positive‡ (%) | 60 | 8 |
ESR, mm/h (mean, ± SD) | 27 (± 26) | 16 (± 13) |
Serum IgG, mg/dL (mean, ± SD) | 1640 (± 857) | 1162 (± 291) |
Minor salivary gland biopsy and focus score data was available for all subjects. A focus score of 1 or greater is needed to show histopathological evidence of Sjögren’s syndrome.;
Anti-SSA and SSB reference (0–19 EU).;
Rheumatoid Factor reference (< 20 IU/mL).